Table 2

Table 2. Summary of key recommendations to optimise patient outcomes on ibrutinib therapy. Adapted with permission from Gribben JL et al. Br J Haematol 2018;180:666–79.42

Table 2. Summary of key recommendations to optimise patient outcomes on ibrutinib therapy. Adapted with permission from Gribben JL et
al. Br J Haematol 2018;180:666–79.42

Table 2. Summary of key recommendations to optimise patient outcomes on ibrutinib therapy. Adapted with permission from Gribben JL et
al. Br J Haematol 2018;180:666–79.42